600230.SS
Cangzhou Dahua Co., Ltd. [600230.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600230.SS Stock Summary
Top 10 Correlated ETFs
600230.SS
Top 10 Correlated Stocks
600230.SS
In the News
600230.SS Financial details
Company Rating
Buy
Market Cap
4.6B
Income
436.87M
Revenue
5.17B
Book val./share
9.78
Cash/share
1.19
Dividend
0.3
Dividend %
2.31%
Employees
1.15K
Optionable
No
Shortable
Yes
Earnings
24 Aug 2023
P/E
12.43
Forward P/E
-
PEG
1.27
P/S
1.04
P/B
1.35
P/C
8.9
P/FCF
7.14
Quick Ratio
0.87
Current Ratio
1.2
Debt / Equity
0.28
LT Debt / Equity
0.26
-
-
EPS (TTM)
1.05
EPS next Y
-
EPS next Q
-
EPS this Y
92.45%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-15.8%
Revenue last 5Y
2.09%
Revenue Q/Q
23.54%
EPS Q/Q
75%
-
-
-
-
SMA20
-
SMA50
-8.33%
SMA100
-21.43%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
11%
ROC
0.08%
Gross Margin
17%
Oper. Margin
9%
Profit Margin
8%
Payout
26%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.22-18.0
52W High
-41.17%
52W Low
+32.38%
RSI
44
Rel Volume
1.47
Avg Volume
4.6M
Volume
6.77M
Perf Week
-5.61%
Perf Month
1.53%
Perf Quarter
-14.94%
Perf Half Y
-23.87%
-
-
-
-
Beta
0.477
-
-
Volatility
0.43%, 0.36%
Prev Close
2.52%
Price
10.59
Change
3.32%
600230.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 10.76 | 5.11 | 4.01 | 5.8 | 11.93 | |
| Net income per share | 2.41 | 0.06 | 0.03 | 0.53 | 1.02 | |
| Operating cash flow per share | 3.64 | 0.3 | 0.41 | 0.92 | 1.28 | |
| Free cash flow per share | 3.46 | -0.98 | -2.27 | -4.06 | 0.31 | |
| Cash per share | 4.31 | 3.17 | 2.65 | 1.04 | 1.02 | |
| Book value per share | 8.71 | 8.6 | 8.68 | 9.19 | 9.56 | |
| Tangible book value per share | 9.24 | 8.97 | 9.17 | 9.19 | 9.56 | |
| Share holders equity per share | 8.71 | 8.6 | 8.68 | 9.19 | 9.56 | |
| Interest debt per share | 0.11 | 1.2 | 3.03 | 3.33 | 3.11 | |
| Market cap | 6.62B | 4.25B | 3.74B | 5.86B | 6.79B | |
| Enterprise value | 4.89B | 3.44B | 3.9B | 6.81B | 7.6B | |
| P/E ratio | 6.68 | 164.84 | 278.2 | 26.62 | 16.17 | |
| Price to sales ratio | 1.49 | 2.02 | 2.26 | 2.46 | 1.38 | |
| POCF ratio | 4.41 | 34.94 | 21.91 | 15.56 | 12.87 | |
| PFCF ratio | 4.65 | -10.53 | -4 | -3.51 | 54.02 | |
| P/B Ratio | 1.85 | 1.2 | 1.05 | 1.55 | 1.73 | |
| PTB ratio | 1.85 | 1.2 | 1.05 | 1.55 | 1.73 | |
| EV to sales | 1.1 | 1.63 | 2.36 | 2.85 | 1.55 | |
| Enterprise value over EBITDA | 2.65 | 13.59 | 21.9 | 13.33 | 7.87 | |
| EV to operating cash flow | 3.26 | 28.26 | 22.81 | 18.05 | 14.39 | |
| EV to free cash flow | 3.43 | -8.52 | -4.16 | -4.07 | 60.41 | |
| Earnings yield | 0.15 | 0.01 | 0 | 0.04 | 0.06 | |
| Free cash flow yield | 0.22 | -0.09 | -0.25 | -0.28 | 0.02 | |
| Debt to equity | 0.01 | 0.14 | 0.35 | 0.36 | 0.31 | |
| Debt to assets | 0.01 | 0.1 | 0.2 | 0.19 | 0.17 | |
| Net debt to EBITDA | -0.94 | -3.21 | 0.87 | 1.84 | 0.83 | |
| Current ratio | 4.35 | 3.62 | 1.6 | 0.83 | 0.77 | |
| Interest coverage | 281.64 | -0.54 | -85.37 | 46.05 | 7.79 | |
| Income quality | 1.4 | 4.72 | 12.7 | 1.9 | 1.25 | |
| Dividend Yield | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Payout ratio | 0.17 | 1.77 | 3.39 | 0.3 | 0.17 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0.02 | 0.01 | 0.01 | 0.02 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.02 | 0.04 | 0.04 | |
| Capex to operating cash flow | -0.05 | -4.32 | -6.48 | -5.43 | -0.76 | |
| Capex to revenue | -0.02 | -0.25 | -0.67 | -0.86 | -0.08 | |
| Capex to depreciation | -0.26 | -2.07 | -4.4 | -7.15 | -0.91 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Graham number | 21.72 | 3.48 | 2.53 | 10.52 | 14.81 | |
| ROIC | 0.3 | 0 | -0.02 | 0.04 | 0.08 | |
| Return on tangible assets | 0.22 | 0.01 | 0 | 0.03 | 0.06 | |
| Graham Net | 3.56 | 1.58 | -1.89 | -4.78 | -3.94 | |
| Working capital | 1.88B | 1.41B | 750.93M | -316.38M | -467.18M | |
| Tangible asset value | 3.8B | 3.69B | 3.78B | 3.79B | 3.94B | |
| Net current asset value | 1.8B | 900.88M | -461.35M | -1.55B | -1.23B | |
| Invested capital | 0.01 | 0.14 | 0.35 | 0.36 | 0.31 | |
| Average receivables | 670.46M | 410.88M | 551.49M | 669.52M | 702.45M | |
| Average payables | 390.48M | 292.08M | 440.51M | 792.37M | 815.15M | |
| Average inventory | 111.07M | 110.48M | 159.08M | 245.66M | 357.25M | |
| Days sales outstanding | 31.72 | 75.68 | 147.12 | 102.84 | 54.39 | |
| Days payables outstanding | 56.71 | 42.31 | 158.12 | 171.34 | 62.98 | |
| Days of inventory on hand | 13.25 | 26.49 | 43.55 | 57.41 | 36 | |
| Receivables turnover | 11.51 | 4.82 | 2.48 | 3.55 | 6.71 | |
| Payables turnover | 6.44 | 8.63 | 2.31 | 2.13 | 5.8 | |
| Inventory turnover | 27.55 | 13.78 | 8.38 | 6.36 | 10.14 | |
| ROE | 0.28 | 0.01 | 0 | 0.06 | 0.11 | |
| Capex per share | -0.18 | -1.28 | -2.69 | -4.97 | -0.98 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.95 | 3.52 | 2.79 | 2.79 | 3.45 | |
| Net income per share | 0.08 | 0.55 | 0.17 | 0.12 | 0.21 | |
| Operating cash flow per share | 0.08 | 0.55 | 0.17 | 0.63 | 0.66 | |
| Free cash flow per share | -0.26 | 0.51 | 0.13 | 0.59 | 0.6 | |
| Cash per share | 1.51 | 1.02 | 0.88 | 1.36 | 1.19 | |
| Book value per share | 9.46 | 9.56 | 9.75 | 9.88 | 9.78 | |
| Tangible book value per share | 9.45 | 9.56 | 9.61 | 9.76 | 9.69 | |
| Share holders equity per share | 9.46 | 9.56 | 9.75 | 9.88 | 9.78 | |
| Interest debt per share | 3.41 | 3.01 | 3.01 | 2.99 | 2.74 | |
| Market cap | 8.4B | 6.79B | 7.17B | 6.05B | 5.77B | |
| Enterprise value | 9.18B | 7.6B | 8.04B | 6.7B | 6.4B | |
| P/E ratio | 64.74 | 7.44 | 25 | 30.49 | 16.54 | |
| Price to sales ratio | 6.8 | 4.69 | 6.24 | 5.26 | 4.06 | |
| POCF ratio | 258.97 | 29.75 | 100 | 23.13 | 21.16 | |
| PFCF ratio | -77.21 | 32.3 | 134.89 | 24.8 | 23.5 | |
| P/B Ratio | 2.12 | 1.73 | 1.79 | 1.49 | 1.43 | |
| PTB ratio | 2.12 | 1.73 | 1.79 | 1.49 | 1.43 | |
| EV to sales | 7.43 | 5.24 | 6.99 | 5.83 | 4.5 | |
| Enterprise value over EBITDA | 179.25 | 29.95 | 76.22 | 109.4 | 64.52 | |
| EV to operating cash flow | 283.01 | 33.27 | 112.08 | 25.65 | 23.46 | |
| EV to free cash flow | -84.38 | 36.12 | 151.2 | 27.5 | 26.05 | |
| Earnings yield | 0 | 0.03 | 0.01 | 0.01 | 0.02 | |
| Free cash flow yield | -0.01 | 0.03 | 0.01 | 0.04 | 0.04 | |
| Debt to equity | 0.36 | 0.31 | 0.31 | 0.3 | 0.28 | |
| Debt to assets | 0.19 | 0.17 | 0.17 | 0.18 | 0.16 | |
| Net debt to EBITDA | 15.23 | 3.17 | 8.22 | 10.75 | 6.32 | |
| Current ratio | 0.75 | 0.77 | 0.92 | 1.23 | 1.2 | |
| Interest coverage | 3.06 | 15.84 | 8.09 | 3.82 | 9.24 | |
| Income quality | 1 | 1 | 1 | 5.27 | 3.13 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
| Payout ratio | 0.87 | 0.06 | 0.18 | 0.21 | 0.9 | |
| Sales general and administrative to revenue | 0.1 | -0.07 | 0.05 | -0.04 | 0.11 | |
| Research and developement to revenue | 0.01 | 0.02 | 0.03 | 0.04 | 0.03 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | |
| Capex to operating cash flow | -4.35 | -0.08 | -0.26 | -0.07 | -0.1 | |
| Capex to revenue | -0.11 | -0.01 | -0.02 | -0.02 | -0.02 | |
| Capex to depreciation | -1.31 | -0.17 | -0.15 | -0.14 | 0.11 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0.01 | -0.01 | |
| Graham number | 4.06 | 10.92 | 6.18 | 5.17 | 6.83 | |
| ROIC | 0.01 | 0.04 | 0.01 | 0.01 | 0.02 | |
| Return on tangible assets | 0 | 0.03 | 0.01 | 0.01 | 0.01 | |
| Graham Net | -4.6 | -3.94 | -3.86 | -3.28 | -3.16 | |
| Working capital | -566.11M | -467.18M | -138.52M | 304.23M | 269.41M | |
| Tangible asset value | 3.95B | 3.94B | 3.96B | 4.02B | 3.99B | |
| Net current asset value | -1.57B | -1.23B | -1.11B | -966.65M | -902.02M | |
| Invested capital | 0.36 | 0.31 | 0.31 | 0.3 | 0.28 | |
| Average receivables | 678.71M | 715.59M | 761.49M | 681.16M | 633.09M | |
| Average payables | 846.5M | 786.64M | 697.08M | 630.66M | 539.6M | |
| Average inventory | 409.37M | 375.73M | 475.24M | 503.85M | 448.44M | |
| Days sales outstanding | 50.96 | 45.48 | 61.92 | 44.72 | 43.99 | |
| Days payables outstanding | 68.73 | 57.69 | 64.52 | 53.17 | 36.78 | |
| Days of inventory on hand | 27.5 | 32.98 | 51.39 | 42.63 | 31.81 | |
| Receivables turnover | 1.77 | 1.98 | 1.45 | 2.01 | 2.05 | |
| Payables turnover | 1.31 | 1.56 | 1.39 | 1.69 | 2.45 | |
| Inventory turnover | 3.27 | 2.73 | 1.75 | 2.11 | 2.83 | |
| ROE | 0.01 | 0.06 | 0.02 | 0.01 | 0.02 | |
| Capex per share | -0.34 | -0.04 | -0.05 | -0.04 | -0.07 |
600230.SS Frequently Asked Questions
What is Cangzhou Dahua Co., Ltd. stock symbol ?
Cangzhou Dahua Co., Ltd. is a CN stock and trading under the symbol 600230.SS
What is Cangzhou Dahua Co., Ltd. stock quote today ?
Cangzhou Dahua Co., Ltd. stock price is $10.59 today.
Is Cangzhou Dahua Co., Ltd. stock public?
Yes, Cangzhou Dahua Co., Ltd. is a publicly traded company.
Company Profile
- Volume Average 4.6M
- Market Capitalization 4.6B
- Employee 1.15K
- CEO Ms. Yuexiang Ma
- Headquarters Cangzhou,CN
- IPO Date 2000-04-06
-
Website
https://www.czdh.chemchina.com/czdhen/cpyfw/gscp/webinfo/2012/08/1345169337774222.htm 
Cangzhou Dahua Co., Ltd. produces and sells chemical fertilizers and carbimides in China. The company offers synthetic ammonia, urea, hydrochloric acid, toluene-diisocyanate, and concentrated nitric acid. It also exports its products to Southeast Asia, Japan, and South Korea. The company was founded in 1974 and is based in Cangzhou, China.
